Sunesis Pharmaceuticals CSO Judith Fox receives $556K in 2019
Sunesis Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Sunesis Pharmaceuticals reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, three executives at Sunesis Pharmaceuticals received on average a compensation package of $480K, a 11% decrease compared to previous year.
Average pay of disclosed executives at Sunesis Pharmaceuticals
Judith A. Fox, Chief Scientific Officer, received $556K in total. 69% of Fox's compensation, or $385K, was in salary. Fox also received $87K in non-equity incentive plan, $79K in option awards, as well as $5.3K in other compensation.
William P. Quinn, Chief Financial Officer, received a compensation package of $546K, which increased by 9% compared to previous year. 72% of the compensation package, or $391K, was in salary.
Dayton Misfeldt, Chief Executive Officer, earned $340K in 2019, a 41% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2020.